Quantbot Technologies LP Wave Life Sciences Ltd. Transaction History

Quantbot Technologies LP

  • $2.5 Billion
  • Q4 2024

A detailed history of Quantbot Technologies LP transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Quantbot Technologies LP holds 68,927 shares of WVE stock, worth $727,869. This represents 0.03% of its overall portfolio holdings.

Number of Shares
68,927
Holding current value
$727,869
% of portfolio
0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$8.0 - $16.44 $551,416 - $1.13 Million
68,927 New
68,927 $852,000
Q1 2021

May 14, 2021
SELL
$5.61 - $12.01 $25,665 - $54,945
-4,575 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$6.99 - $9.26 $20,236 - $26,807
2,895 Added 172.32%
4,575 $36,000
Q3 2020

Nov 16, 2020
BUY
$8.49 - $19.54 $11,716 - $26,965
1,380 Added 460.0%
1,680 $14,000
Q2 2020

Aug 13, 2020
BUY
$7.44 - $11.29 $2,232 - $3,386
300 New
300 $3,000
Q1 2020

May 13, 2020
SELL
$6.94 - $14.22 $15,136 - $31,013
-2,181 Closed
0 $0
Q4 2019

Feb 10, 2020
SELL
$7.99 - $37.6 $53,101 - $249,889
-6,646 Reduced 75.29%
2,181 $17,000
Q3 2019

Nov 12, 2019
BUY
$19.17 - $27.4 $169,213 - $241,859
8,827 New
8,827 $181,000
Q4 2018

Feb 13, 2019
SELL
$37.1 - $50.11 $52,533 - $70,955
-1,416 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$36.35 - $55.2 $51,471 - $78,163
1,416 New
1,416 $70,000
Q2 2018

Aug 13, 2018
SELL
$33.85 - $50.65 $74,233 - $111,075
-2,193 Closed
0 $0
Q1 2018

May 11, 2018
BUY
$32.45 - $54.7 $71,162 - $119,957
2,193 New
2,193 $87,000

Others Institutions Holding WVE

# of Institutions
191
Shares Held
122M
Call Options Held
430K
Put Options Held
330K
View Full List

About Wave Life Sciences Ltd.

WVE Quotes by TradingView
  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $917M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email